Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40
…, C Rickards, MB Powell, BP McSharry, S Gadola… - Science, 2000 - science.org
The nonclassical major histocompatibility complex (MHC) class I molecule HLA-E inhibits
natural killer (NK) cell–mediated lysis by interacting with CD94/NKG2A receptors. Surface …
natural killer (NK) cell–mediated lysis by interacting with CD94/NKG2A receptors. Surface …
The crystal structure of human CD1d with and without α-galactosylceramide
M Koch, VS Stronge, D Shepherd, SD Gadola… - Nature …, 2005 - nature.com
The glycolipid α-galactosylceramide binds with high affinity to CD1d and stimulates natural
killer T cells. Here we report the crystal structure of human CD1d in complex with synthetic α-…
killer T cells. Here we report the crystal structure of human CD1d in complex with synthetic α-…
Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals
Invariant natural killer T cells (iNKT cells) have a prominent role during infection and other
inflammatory processes, and these cells can be activated through their T cell antigen …
inflammatory processes, and these cells can be activated through their T cell antigen …
Structure of human CD1b with bound ligands at 2.3 Å, a maze for alkyl chains
The human genome encodes five nonpolymorphic major histocompatibility complex class I–like
glycoproteins, CD1a to CD1e, that present lipid antigens for specific recognition by T …
glycoproteins, CD1a to CD1e, that present lipid antigens for specific recognition by T …
Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon γ …
G Matulis, P Jüni, PM Villiger, SD Gadola - Annals of the rheumatic …, 2008 - ard.bmj.com
Objective: To analyse the performance of a new M tuberculosis-specific interferon γ (IFNγ)
assay in patients with chronic inflammatory diseases who receive immunosuppressive drugs, …
assay in patients with chronic inflammatory diseases who receive immunosuppressive drugs, …
Anti-TNF-induced lupus
EL Williams, S Gadola, CJ Edwards - Rheumatology, 2009 - academic.oup.com
The use of protein-based anti-TNF-α therapies such as antibodies and soluble TNF-α
receptors is commonly associated with the induction of autoantibodies, whereas anti-TNF-induced …
receptors is commonly associated with the induction of autoantibodies, whereas anti-TNF-induced …
Motor control retraining exercises for shoulder impingement: effects on function, muscle activation, and biomechanics in young adults
OBJECTIVE: Evidence for effective management of shoulder impingement is limited. The
present study aimed to quantify the clinical, neurophysiological, and biomechanical effects of a …
present study aimed to quantify the clinical, neurophysiological, and biomechanical effects of a …
[HTML][HTML] Innate and adaptive T cells in asthmatic patients: relationship to severity and disease mechanisms
…, JA Ward, PH Howarth, AF Walls, SD Gadola… - Journal of allergy and …, 2015 - Elsevier
Background Asthma is a chronic inflammatory disease involving diverse cells and mediators
whose interconnectivity and relationships to asthma severity are unclear. Objective We …
whose interconnectivity and relationships to asthma severity are unclear. Objective We …
[HTML][HTML] Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease
…, G Angco, D Sammut, SD Gadola… - … England Journal of …, 2007 - Mass Medical Soc
Background The number of type 2 helper CD4+ T cells is increased in the airways of
persons with asthma. Whether the majority of these cells are class II major-histocompatibility-…
persons with asthma. Whether the majority of these cells are class II major-histocompatibility-…
[HTML][HTML] Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled …
…, V Harris, R Djukanovic, S Gadola… - The Lancet …, 2021 - thelancet.com
Background Doxycycline is often used for treating COVID-19 respiratory symptoms in the
community despite an absence of evidence from clinical trials to support its use. We aimed to …
community despite an absence of evidence from clinical trials to support its use. We aimed to …